MME DANIELE PARIENTE

Rhumatologue

RPPS 10001413821

📊 Reconnaissance scientifique : 30/100📝 72 articles publiés🇫🇷 Publications académiques françaises (6)

✨ Génération du profil synthétique IA en cours…

Activité de recherche & publications

Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.

Influence scientifique

30 articles ont été cités au moins 30fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.

Top publications · les plus citées

Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study

The Lancet. Oncology · 2013

📚 240 citations🎯 RCR 8.24Top 4% NIH🔓 Open Access📄 PDF gratuit ↗

2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group

Pediatric radiology · 2007

📚 225 citations🎯 RCR 7.12Top 4% NIH🔓 Open Access📄 PDF gratuit ↗

Complications of congenital portosystemic shunts in children: therapeutic options and outcomes

Journal of pediatric gastroenterology and nutrition · 2010

📚 186 citations🎯 RCR 7.89Top 4% NIH

Lire l'abstract Crossref ↓

ABSTRACTBackground and Objective:Congenital portosystemic shunts are rare vascular malformations that lead to severe complications. Their management is controversial. The aim of this study was to propose a clear definition of the risks and management of congenital portosystemic shunts in children according to our experience and a review of the literature.Patients and Methods:Twenty‐two children with a complicated congenital portosystemic shunt were studied in our institution. When necessary, management included portal pressure measurement and portal vein angiography during an occlusion test and closure of the shunt by surgical and/or endovascular methods.Results:Five neonates with intrahepatic shunts presented with cholestasis that resolved spontaneously, and 17 older children presented with liver tumors (13) and/or hepatopulmonary syndrome (2), pulmonary artery hypertension (3), portosystemic encephalopathy (3), heart failure (1), and glomerulonephritis (1). The portosystemic shunt was extrahepatic (11) or intrahepatic (6). Portosystemic shunts were closed by endovascular methods in 5 children and surgically in 10, 4 of whom had portal pressure during occlusion above 35 mmHg and extremely hypoplastic or undetectable portal veins requiring banding of the fistula before closure. Shunt closure resulted in restoration of intrahepatic portal flow in all, with complete or partial regression of benign liver masses, and regression or stabilization of pulmonary, cardiac, neurological, and renal complications.Conclusions:Congenital portosystemic shunt carries risks of severe complications in children. Closure of a shunt persisting after age 2 years should be considered preventively. Intrahepatic portal flux restoration can be expected, even when intrahepatic portal veins are extremely hypoplastic or undetectable.

Cookies & analyse de trafic

MME DANIELE PARIENTE

Pourquoi vous devez consulter ce praticien

Activité de recherche & publications

Publications académiques en France

Lieu de consultation

Tarifs & secteur de conventionnement

Prendre rendez-vous & contact

Top publications · les plus citées

Publications scientifiques (40) — classées par pathologie

Pédiatrie36

Transversal4

Essai clinique3

Case report / série2

Pharmacovigilance2

Épidémiologie & registres1

Revue / méta-analyse1

Revue générale1

Partager cette fiche